Clinical Trial Update: Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study

View source ↗

Summary

A retrospective, single-center study assessing the use and experience with Oncotype DX in BRCA-mutated breast cancer patients, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Breast Cancer, Genetic Predisposition | Status: COMPLETED